Overview
Michelle Shen is a Surgical Oncologist and a General Surgeon in Sugar Land, Texas. Dr. Shen is rated as an Experienced provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Intraductal Papilloma, Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Lymphadenectomy. Dr. Shen is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
Accepted plan types not found. Please verify directly with the provider.
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
17510 W Grand Pkwy S, Suite 190, Sugar Land, TX 77479
MD Anderson
Henry Kuerer is a Surgical Oncologist in Houston, Texas. Dr. Kuerer is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.
MD Anderson
Sarah Desnyder is a General Surgeon and a Surgical Oncologist in Houston, Texas. Dr. Desnyder is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Paget Disease of the Breast, Mastectomy, and Lymphadenectomy.
Baylor St. Luke's - O’Quinn Medical Tower At McNair
Dr. Alastair Thompson is a surgical oncologist specializing in breast cancer. He is the Professor and Chief of the Division of Surgical Oncology, Section of Breast Surgery at Baylor College of Medicine, where he holds the Olga Keith Wiess Chair of Surgery. He also serves as Co-Director of the Lester and Sue Smith Breast Center and is Co-Associate Director for Clinical Research at the Dan L Duncan Comprehensive Cancer Center.Dr. Thomspon’s clinical interests include: ductal carcinoma in situ (DCIS); nipple and skin sparing mastectomy; breast conservation surgery; and sentinel lymph node biopsy. His research interests include: multidisciplinary patient care alongside “bench to bedside” studies; and innovative clinical trials in cancer. He initiated and led a successful breast cancer laboratory program; provided leadership for a cancer center in the United Kingdom; chaired the UK national breast cancer trials portfolio of 120 studies; and engaged in a range of pivotal roles in key drug, radiation therapy and surgical trials involving the UK, Europe, United States and Australia.Dr. Thompson also has preclinical and practical experience in the design, implementation, monitoring and reporting of early- to late-phase drug and medical device trials. Dr. Thompson received his MBChB in Medicine Surgery and medical degree in Molecular Biology from the University of Edinburgh in Edinburgh, Scotland. He completed his residency in general surgery at the Royal Infirmary of Edinburgh and a Research Fellowship at the Imperial Cancer Research Fund in Edinburgh.Dr. Thompson has co-chaired the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for low-risk DCIS; and the National Cancer Institute (NCI)-Breast Cancer Steering Committee proposed “no surgery” clinical trial planning committee. He is a member of the NCI BOLD taskforce and has held leadership positions in the Translational Breast Cancer Research Consortium and SWOG Cancer Research Network.Dr. Thompson is also a member of the American Society of Clinical Oncology, Association of Breast Surgery, British Association of Surgical Oncology, British Breast Group, American Society of Breast Surgeons, American Association for Cancer Research, Moynihan Chirurgical Club, and the Society of Surgical Oncology. Dr. Thompson is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Tissue Biopsy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Shen isAdvanced. Learn about Breast Cancer.
- Intraductal PapillomaDr. Shen isAdvanced. Learn about Intraductal Papilloma.
- Paget Disease of the BreastDr. Shen isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- AngiosarcomaDr. Shen isExperienced. Learn about Angiosarcoma.
- Breast InfectionDr. Shen isExperienced. Learn about Breast Infection.
- Breast LumpDr. Shen isExperienced. Learn about Breast Lump.
- FibroadenomaDr. Shen isExperienced. Learn about Fibroadenoma.
- Giant Mammary HamartomaDr. Shen isExperienced. Learn about Giant Mammary Hamartoma.
- Inflammatory Breast CancerDr. Shen isExperienced. Learn about Inflammatory Breast Cancer.

